The retinal laser photocoagulation market is projected to grow from USD 266.1 billion in 2025 to USD 408.1 billion by 2035, at a CAGR of 4.4%. Argon Laser (488 Nm) will dominate with a 41.7% market share, while proliferative diabetic retinopathy (pdr) will lead the indication segment with a 44.2% share.